Introduction
Heavy-ion therapy plays an important role in the treatment of radiation-resistant tumors. This procedure heavily relies on the inverted depth dose distbution method and the superior radiobiological effect characteristics of heavy-ion beam radiation in reducing the dose exposure to normal tissues. Among the various types of heavy-ion beams, carbon-ion beams are currently the most suitable for clinical treatment [1]. The Institute of Modern Physics (IMP) used the Lanzhou heavy ion research facility (HIRFL) to conduct preclinical trials on heavy-ion cancer treatment in China. Subsequently, IMP, in cooperation with Lanzhou Kejintaiji Co., Ltd., independently developed the first medical heavy-ion accelerator demonstration device in China (product model: HIMM-GS1-WW1). The device is in service in Wuwei and Gansu, whereas it has been installed in Lanzhou and is in the commissioning, monitoring, and registration phases. In addition, carbon-ion particle therapy systems have been set up in Fujian, Zhejiang, and other regions [2]. With the increased deployment of carbon-ion radiotherapy (CIRT), research on the associated radiation problems is required.
The carbon-ion beam profile is modulated by the beam delivery system before irradiation owing to the fact that the profile appears diminished after it is withdrawn from the accelerator. This passive beam delivery method uses configured hardware components to make the beam more conformal and thus demonstrates improved reliability, lower time consumption, insensitivity to target movement, and strong anti-interference ability [3]. However, the use of hardware components has significantly increased the secondary radiation dose outside the primary field because secondary particles, such as neutrons, are generated when a beam interacts with a phantom or patient. Several studies have indicated that secondary neutrons in radiotherapy have a broad energy spectrum: for high-energy photon (>10
Experimental studies have indicated that the ambient dose equivalent per therapeutic dose (
In this study, we used the Monte Carlo method to estimate neutron ambient dose equivalents in a patient’s environment for passive CIRT using a heavy-ion medical machine. The variation law of
Materials and Methods
Monte Carlo simulations
The HIMM has four treatment terminals with active and passive beam delivery methods. The treatment terminals were used for irradiation from different directions: horizontal, vertical, horizontal + vertical, and 45° inclination. The dose rate at the isocenter was 0.001-1
The beamline setting of the HIMM Room 2 in the Monte Carlo simulation is shown in Fig. 1. Prior research has shown that
-202209/1001-8042-33-09-011/alternativeImage/1001-8042-33-09-011-F001.jpg)
Component | Material | Density( |
Distance to isocenter( |
---|---|---|---|
Pre-collimator | Cu-100% | 8.96 | 357 |
Ridge filter | Al-100% | 2.7 | 236 |
Multileaf collimator | Cu-5% W-95% | 18.23 | 72 |
The neutron spectral fluence was tallied into a set of 12-cm-diameter spherical receptors. A total of 16 receptors were located at the isocenter at distances of 25, 50, 100, 150, and 200 cm from the isocenter and angles of 0, 45, and 90° for the incident beam direction (see Fig. 1) [15-16]. The neutron spectral fluence
The secondary neutron fluence spectrum for the HIMM passive beam delivery system was calculated using the GATE v8.2/Geant4-10-05. Geant4 (geometry and tracking) is a set of Monte Carlo toolkits developed by CERN, using object-oriented technology based on C++, and its purpose is to simulate the physical process of particle transportation in matter [23]. Owing to its flexibility, Geant4 is also widely used in high-energy physics, nuclear physics, space and astrophysics, and radiation protection and detection, and it can be applied to the field of medical physics with the addition of expansion packages. GATE was designed by the OpenGATE team, based on the Geant4 kernel. This simulation platform is mainly used for Monte Carlo simulations of computed tomography and can also simulate particle radiotherapy.
The electromagnetic and hadronic physical processes were implemented using the physics list QGSP_BERT_HP_EMV, according to the recommendation from the OpenGATE collaboration. The cut (production threshold) for particle transport was 1 mm.
Calculation of ambient dose equivalent and values
To assess neutron exposure at various locations, the focus was first on the ambient dose equivalent obtained using the fluence spectrum and neutron fluence-to-ambient dose-equivalent conversion coefficients.
-202209/1001-8042-33-09-011/alternativeImage/1001-8042-33-09-011-F002.jpg)
The
Beam energy ( |
RBE |
---|---|
165 | 1.729 |
200 | 1.727 |
250 | 1.718 |
300 | 1.695 |
350 | 1.668 |
400 | 1.636 |
value analytical model from Newhauser and co-workers
The spatial distribution law of
The effective neutron point source distance d is defined as:
Inspired by this conclusion, Zheng et al. proposed an ambient dose-equivalent analytical model for a treatment room [16]. Using Eq. (5), the
Results and Discussion
Characteristics of secondary neutron fluence spectrum and ambient dose equivalent spectrum
The simulated neutron fluence spectrum and its corresponding ambient dose-equivalent spectrum for beam energies of 165, 200, 250, 300, 350, and 400
-202209/1001-8042-33-09-011/alternativeImage/1001-8042-33-09-011-F003.jpg)
(SOBP width is 6 cm, MLC is closed)
These results are consistent with previously published results [5,28], except for the absence of a thermal neutron peak at approximately
Effect of spatial distance on the value
The
-202209/1001-8042-33-09-011/alternativeImage/1001-8042-33-09-011-F004.jpg)
Direction (°) | |
|
|
---|---|---|---|
0 | 1.97667 | 72.3456 | 7.97×10-5/34 |
45 | 1.85566 | 72.9878 | 3.22×10-2/34 |
90 | 1.6191 | 76.124 | 0.37/34 |
As shown in Fig. 4, the
Effect of SOBP width on value
The 2-, 4-, 6-, 8-, 10-, and 12-cm SOBP widths and standardized simulation data based on the 6 cm result were selected. Figure 5 shows the variations in the relative
-202209/1001-8042-33-09-011/alternativeImage/1001-8042-33-09-011-F005.jpg)
The equation in this figure represents the coefficient
Effect of aperture size on value
Based on simulations using aperture sizes α from 0
-202209/1001-8042-33-09-011/alternativeImage/1001-8042-33-09-011-F006.jpg)
The secondary neutron dose equivalent is inversely proportional to the opening size of the MLC. The relative
As shown in Fig. 7, the decreasing laws of the
-202209/1001-8042-33-09-011/alternativeImage/1001-8042-33-09-011-F007.jpg)
Because there is no interference from escaped high-energy neutrons in the 45° direction, the falling laws of the
Coefficient
-202209/1001-8042-33-09-011/alternativeImage/1001-8042-33-09-011-F008.jpg)
Direction (°) | |
|
|
---|---|---|---|
0 | -3.63303×10-3 | 0.958614 | 0.201/34 |
45 | -4.19874×10-3 | 0.971873 | 0.062/34 |
90 | -4.03541×10-3 | 1.01711 | 0.23/34 |
Validation of the analytical model
The predicted values
Out-of-field neutron dose performance evaluation
The
-202209/1001-8042-33-09-011/alternativeImage/1001-8042-33-09-011-F009.jpg)
-202209/1001-8042-33-09-011/alternativeImage/1001-8042-33-09-011-F010.jpg)
Beam energy |
Beam range in water |
Type of beam delivery | Data acquisition method | Aperture size of MLC |
SOBP width |
phantom at iso | |
---|---|---|---|---|---|---|---|
Yan et al.[10] | 160(p) | 16 | Passive | Measured | 5 × 5 | 8.2 | Yes |
Zheng et al.[16] | 160(p) | 16 | Passive | MCNP simulated | 5 × 5 | 8.2 | No |
Polf et al.[15] | 158(p) | 15.8 | Passive | MCNP simulated | 5 × 5 | 15 | Yes |
Schneider et al.[29] | 177(p) | — | Spot scanning | FLUKA simulated | — | — | Yes |
Yonai et al.[11] | 320(C) | 16.3 | Passive | Measured | 5.3 × 5 | 6 | Yes |
This work | 300(C) | 16.5 | Passive | GATE simulated | 0 × 0 | 6 | No |
The neutron ambient dose equivalents in carbon and proton radiotherapy are comparable in the horizontal direction of the out-of-field area. A popular explanation for this phenomenon is that the cross section for nuclear interactions is higher for carbon-ion beams than for proton beams, but fewer carbon ions are required to deliver the same therapeutic dose: approximately
Compared to the experimental measurement data of the carbon-ion radiotherapy device of the Hyogo Ion Beam Medical Center (HIBMC) by Yonai et al., the simulation results in this study were 20 times greater [11]. This discrepancy may originate from the difference between the beamline components and the calculation method. (1) The collimator system in this study is composed of a fixed primary collimator and a 6.48-cm thick tungsten copper alloy MLC. In reference 10, an adjustable four-leaf collimator was used for collimation in advance to reduce the beam profile to the required field size, and a 140-mm thick iron MLC was used, which could significantly reduce the neutron dose. (2) Reference 10 used the WENDI-II wide-energy neutron dose equivalent monitor for measurement, whereas this study used the Monte Carlo method for calculation. The Monte Carlo method results in a calculated value that is larger than the measured value [33].
Conclusion
In this study, the Monte Carlo method was used to calculate the external neutron ambient dose equivalent, which was generated in the passive beam delivery system for the HIMM facility in Wuwei, and an analytical model for the
At present, most neutron detectors have limited responses at energies greater than 20
Although the results of the present study are based on the HIMM facility in Wuwei, owing to the similarity of passive beam delivery systems, the simulation method is also applicable to other machines equipped with passive systems. The configurations in this work (free beam condition, closed MLC) are conservative, mainly focusing on the external neutrons produced by the beamline components.
There is growing evidence that the hazard of non-therapeutic neutron radiation generated during radiotherapy is nonnegligible and worthy of further investigation. This work contributes to our understanding of non-therapeutic radiation during CIRT and provides a basis for further reduction and accurate assessment of the neutron radiation received by patients, especially for pediatric and young patients with long life expectancy.
Tumor therapy with heavy charged particles
. Prog. Part. Nucl. Phys. 45, 473-544 (2000). doi: 10.1016/S0146-6410(00)00112-5The development and commercialization of carbon ion cancer therapy facility
. Innovation in China 16, 9-17 (2020). doi: 10.11842/chips.20200310002 (in Chinese)Particle Therapy Facilities in Clinical Operation
, https://www.ptcog.ch/index.php/facilities-in-operation; 2022 [accessedSecondary neutron spectra from modern Varian, Siemens, and Elekta linacs with multileaf collimators
. Med. Phys. 36, 4027-4038 (2009). doi: 10.1118/1.3159300Secondary neutron spectrum from 250-MeV passively scattered proton therapy: measurement with an extended-range bonner sphere system
. Med. Phys. 41, 092104 (2014). doi: 10.1118/1.4892929Secondary neutrons in clinical proton radiotherapy: a charged issue
. Radiother. Oncol. 86, 165-170 (2008). doi: 10.1016/j.radonc.2007.12.003Radiation dose effects on the morphological development of M1 generation pea (Pisum sativum)
. Nucl. Sci. Tech. 32, 124 (2021). doi: 10.1007/s41365-021-00962-3Secondary dose exposures during 200 MeV proton therapy
. Radiat. Prot. Dosim. 70, 441-444 (1997). doi: 10.1093/oxfordjournals.rpd.a031993Secondary neutron and photon dose in proton therapy
. Radiother. Oncol. 48, 293-305 (1998). doi: 10.1016/S0167-8140(98)00049-8Measurement of neutron dose equivalent to proton therapy patients outside of the proton radiation field
. Nucl. Instrum. Meth. Sect. A 476, 429-434 (2002). doi: 10.1016/S0168-9002(01)01483-8Measurement of neutron ambient dose equivalent in passive carbon-ion and proton radiotherapies
. Med. Phys. 35, 4782-4792 (2008). doi: 10.1118/1.2989019Measurements of neutron dose equivalent for a proton therapy center using uniform scanning proton beams
. Med. Phys. 39, 3484-3492 (2012). doi: 10.1118/1.4718685Study of neutron dose equivalent at the HIRFL deep tumor therapy terminal
. Chinese Phys. C 41, 068201 (2017). doi: 10.1088/1674-1137/41/6/068201Calibration of a neutron dose rate meter in various neutron standard fields
. Nucl. Sci. Tech. 31, 60 (2020). doi: 10.1007/s41365-020-00763-0Calculations of neutron dose equivalent exposures from range-modulated proton therapy beams
. Phys. Med. Biol. 50, 3859-3873 (2005). doi: 10.1088/0031-9155/50/16/014Monte Carlo study of neutron dose equivalent during passive scattering proton therapy
. Phys. Med. Biol. 52, 4481-4496 (2007). doi: 10.1088/0031-9155/52/15/008Monte Carlo study on secondary neutrons in passive carbon-ion radiotherapy: identification of the main source and reduction
. Med. Phys. 36, 4830-4839 (2009). doi: 10.1118/1.3220624Analysis of influencing factors on the method for determining boron concentration and dose through dual prompt gamma detection
. Nucl. Sci. Tech. 32, 35 (2021). doi: 10.1007/s41365-021-00873-3An analytic model of neutron ambient dose equivalent and equivalent dose for proton radiotherapy
. Phys. Med. Biol. 55, 6975-6985 (2010). doi: 10.1088/0031-9155/55/23/S01Radiation shielding design for treatment room of HIMM
. Atomic Energy Science and Technology. 52, 1118-1123 (2018). doi: 10.1016/j.ijrobp.2006.01.027 (in Chinese)The physics of proton therapy
. Phys. Med. Biol. 60, 155-209 (2015). doi: 10.1088/0031-9155/60/8/R155Absorbed dose determination in external beam radiotherapy
. Technical Reports Series No. 398,Validation of GEANT4, an object-oriented Monte Carlo toolkit, for simulations in medical physics
. Med. Phys. 31, 484-492 (2004). doi: 10.1118/1.1644532Fluence to dose equivalent conversion data and effective quality factors for high energy neutrons
. Radiat. Prot. Dosim. 76, 215-224 (1998). doi: 10.1093/oxfordjournals.rpd.a032267WENDI: An improved neutron rem meter
. Health Phys. 79, 170-181 (2000). doi: 10.1097/00004032-200008000-00010ICRP 74 Conversion Coefficients for Use in Radiological Protection against External Radiation
. Annals of the ICRP. 6, 1 (1981). doi: 10.1016/0146-6453(81)90127-5Protection against neutron radiation
. NCRP Report 38 (1971).Monte Carlo study toward the development of a radiation field to simulate secondary neutrons produced in carbon-ion radiotherapy
. Radiat. Phys. Chem. 172, 108787 (2020). doi: 10.1016/j.radphyschem.2020.108787Secondary neutron dose during proton therapy using spot scanning
. Int. J. Radiat. Oncol. Biol. Phys. 53, 244-251 (2002). doi: 10.1016/S0360-3016(01)02826-7AAPM TG 158: measurement and calculation of doses outside the treated volume from external-beam radiation therapy
. Med. Phys. 44, 391-429 (2017). doi: 10.1002/mp.12462Heavy-ion tumor therapy: physical and radiobiological benefits
. Rev. Mod. Phys. 82, 383-425 (2010). doi: 10.1103/RevModPhys.82.383Assessing the risk of second malignancies after modern radiotherapy
. Nature Reviews Cancer 11, 438-448 (2011). doi: 10.1038/nrc3069Neutron shielding verification measurements and simulations for a 235-MeV proton therapy center
. Nucl. Instrum. Meth. Phys. A 476, 80-84 (2002). doi: 10.1016/S0168-9002(01)01400-0